[{"from": "human", "value": "Please give me some details about this molecule. [C][C@@H1][Branch1][N][C][=N][C][=C][Branch1][Branch1][C][=N][Ring1][=Branch1][F][N][C][=N][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][N][=C][N][Ring1][#Branch1][C][=C][C][=Branch1][Branch1][=N][N][Ring1][Branch1][O][C][Branch1][C][C][C]"}, {"from": "gpt", "value": "The molecule is a tropomyosin receptor kinase (TRK) inhibitor with potential antineoplastic activity. Upon administration, utatrectinib binds to TRK, thereby preventing the neurotrophin-TRK interaction and subsequent TRK activation. This may eventually result in an inhibition of tumor cell proliferation in TRK-expressing tumor cells. TRK, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth, invasion and survival."}]